Skip to main content

Scientists Probe Blockers for the Coronavirus Spike Protein

SARS-CoV-2, the virus that causes COVID-19, taps into human proteases such as furin to enter cells. Temporarily inhibiting those enzymes might stymie infection.

Written byAnthony King
| 6 min read
furin spike protein sars-cov-2 covid-19 coronavirus pandemic

Register for free to listen to this article
Listen with Speechify
0:00
6:00

ABOVE: © ISTOCK.COM, DESIGN CELLS

The pandemic coronavirus SARS-CoV-2 must break into our cells to set up an infection. It gains entry using the now notorious spike protein but, typical of viruses, it must hijack our own biology to jimmy the lock. Scientists are figuring out ways to intercept the virus before it can break in.

Viral spike proteins rely on protein-chomping enzymes, proteases, to re-shape them for cellular entry. In the case of SARS-CoV-2, the spike must first be snipped at a specific point by the furin protease before it latches onto a cell’s ACE2 receptor. Then, another protease must cut the spike protein and initiate viral fusion with the cell membrane.

The idea that researchers are pursuing is to block furin from cutting the spike.

Early on, before COVID-19 was officially declared a pandemic, scientists were already on the furin case, observing that the spike protein had amino ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • anthony king

    Anthony King is a freelance science journalist based in Dublin, Ireland, who contributes to The Scientist. He reports on a variety of topics in chemical and biological sciences, as well as science policy and health. His articles have appeared in Nature, Science, Cell, Chemistry World, New Scientist, the Irish Times, EMBO Reports, Chemistry & Industry, and more. He is President of the Irish Science & Technology Journalists Association. 

    View Full Profile

Related Topics

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays